Arvinas

(NASDAQ) ARVN

Current Price$10.86

Market Cap$672.23M

Since IPO (2018)-35%

5 Year-85%

1 Year+45%

1 Month-7%

Arvinas Financials at a Glance

Market Cap

$672.23M

Revenue (TTM)

$262.60M

Net Income (TTM)

$80.80M

EPS (TTM)

$-1.22

P/E Ratio

-8.64

Dividend

$0.00

Beta (Volatility)

1.43 (Average)

Dividend

$0.00

Beta (Volatility)

1.43 (Average)

Price

$10.86

Volume

60,674

Open

$10.13

Price

$10.86

Volume

60,674

Open

$10.13

Previous Close

$10.51

Daily Range

$9.85 - $10.93

52-Week Range

$5.90 - $14.51

Dividend

$0.00

Beta (Volatility)

1.43 (Average)

Price

$10.86

Volume

60,674

Open

$10.13

Previous Close

$10.51

Daily Range

$9.85 - $10.93

52-Week Range

$5.90 - $14.51

ARVN News

Why Arvinas Jumped 10% Today

James BrumleyJul 22, 2021

Here's Why Arvinas Shares Are Tumbling 13.7% Today

Todd CampbellMay 14, 2020

What Company Will Eli Lilly Buy Next?

David HaenJan 23, 2020

cash-drugs-opportunity-hiding-in-plain-sight

2 Biotech Stocks That Soared Last Week

Cory RenauerOct 28, 2019

ARVN: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Arvinas

Industry

Pharmaceuticals

Sector

Health Care

Employees

246

CEO

John G. Houston, PhD

Website

www.arvinas.com

Headquarters

New Haven, CT 06511, US

ARVN Financials

Key Financial Metrics (TTM)

Gross Margin

100%

Operating Margin

-44%

Net Income Margin

-31%

Return on Equity

-16%

Return on Capital

-20%

Return on Assets

-11%

Earnings Yield

-11.57%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$672.23M

Shares Outstanding

63.96M

Volume

60.67K

Avg. Volume

851.80K

Financials (TTM)

Gross Profit

$257.40M

Operating Income

$114.90M

EBITDA

$75.30M

Operating Cash Flow

$273.80M

Capital Expenditure

$1.90M

Free Cash Flow

$275.70M

Cash & ST Invst.

$685.40M

Total Debt

$8.50M

Arvinas Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$9.50M

-84.0%

Gross Profit

$8.30M

-86.0%

Gross Margin

87.37%

N/A

Market Cap

$672.23M

N/A

Market Cap/Employee

$1.56M

N/A

Employees

430

N/A

Net Income

$67.40M

-49.4%

EBITDA

$66.00M

-16.6%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$676.90M

-34.3%

Accounts Receivable

$6.40M

-53.3%

Inventory

$0.00

N/A

Long Term Debt

$7.20M

-8.9%

Short Term Debt

$1.90M

+5.6%

Return on Assets

-11.26%

N/A

Return on Invested Capital

-20.09%

N/A

Free Cash Flow

$30.60M

+63.7%

Operating Cash Flow

$30.40M

+63.9%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

DNAGinkgo Bioworks Holdings, Inc.

DNAGinkgo Bioworks Holdings, Inc.$10.20+5.15%

MGTXMeiraGTx Holdings plc

MGTXMeiraGTx Holdings plc$9.60+2.02%

VALNValneva SE

VALNValneva SE$5.18-3.08%

GERNGeron Corporation

GERNGeron Corporation$1.57-0.63%

REPLReplimune Group, Inc.

REPLReplimune Group, Inc.$3.02+20.60%

IOVAIovance Biotherapeutics, Inc.

IOVAIovance Biotherapeutics, Inc.$3.75+10.44%

AVBPArriVent BioPharma, Inc. Common Stock

AVBPArriVent BioPharma, Inc. Common Stock$30.05+0.20%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.10-0.02%

INTCIntel

INTCIntel$96.48-0.03%

CNSPCns Pharmaceuticals

CNSPCns Pharmaceuticals$8.02+2.47%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+1.07%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.75+0.01%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.83+0.01%

NCLHNorwegian Cruise Line

NCLHNorwegian Cruise Line$17.12-0.09%

Questions About ARVN

What is the current price of Arvinas?

Arvinas is trading at $10.86 per share.

What is the 52-week range for Arvinas?

Over the past 52 weeks, Arvinas has traded between $5.90 and $14.51.

How much debt does Arvinas have?

As of the most recent reporting period, Arvinas reported total debt of $9.10M.

How much cash does Arvinas have on hand?

Arvinas reported $142.90M in cash and cash equivalents in its most recent financial results.

What is Arvinas’s dividend yield?

Arvinas does not currently have a dividend yield.

Arvinas

Arvinas Financials at a Glance

ARVN News

Why Arvinas Jumped 10% Today

Here's Why Arvinas Shares Are Tumbling 13.7% Today

What Company Will Eli Lilly Buy Next?

2 Biotech Stocks That Soared Last Week

ARVN: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Arvinas

ARVN Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Arvinas Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ARVN

What is the current price of Arvinas?

What is the 52-week range for Arvinas?

How much debt does Arvinas have?

How much cash does Arvinas have on hand?

What is Arvinas’s dividend yield?

Premium Investing Services